RxDoctor Payments Data

Audrey Montooth, MD

Family Medicine · Saint Louis, MONPI 1730132895

Payments from drug & device makers

$1,719in general payments, 2019–2025

Across 105 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$866
  • Pfizer$398
  • Novo Nordisk$103
  • Dexcom, Inc.$66
  • GSK$59
  • Novartis$53
  • plus $174 from 8 others

What the payments were for

  • Food & beverage$1,719100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,719 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$19,365
Medicare patients
49
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide112$124,200
EliquisApixaban169$115,875
MounjaroTirzepatide42$45,679
ProliaDenosumab22$37,089
JardianceEmpagliflozin40$34,253
ArexvyRsvpref3 Antigen/As01e/Pf92$25,750
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,332
XareltoRivaroxaban18$12,743
Buprenorphine50$10,762
Mirabegron ErMirabegron20$9,407
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate25$8,660
Combivent RespimatIpratropium/Albuterol Sulfate18$8,495
FarxigaDapagliflozin Propanediol13$8,382
Semglee (Yfgn) PenInsulin Glargine-Yfgn18$7,675
Dabigatran EtexilateDabigatran Etexilate Mesylate19$7,451

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$103$124,200112 claims
PfizerEliquis$398$115,875169 claims
GSKArexvy, Trelegy Ellipta, Anoro Ellipta$59$44,588125 claims
AmgenProlia$17$37,08922 claims
Astellas Pharma US IncMyrbetriq$29$6,17412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →